Prelude Capital Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-93,668
Closed -$442K 1457
2025
Q4
$442K Sell
93,668
-90,703
-49% -$404K 0.03% 594
2025
Q3
$883K Buy
+184,371
New +$726K 0.07% 336
2024
Q2
Sell
-12,193
Closed -$122K 1394
2024
Q1
$122K Buy
+12,193
New +$107K 0.01% 1181
2022
Q4
Sell
-77,812
Closed -$800K 1508
2022
Q3
$693K Buy
77,812
+6,133
+9% +$70.8K 0.02% 531
2022
Q2
$742K Buy
71,679
+2,311
+3% +$34.3K 0.02% 631
2022
Q1
$1.45M Buy
69,368
+37,610
+118% +$820K 0.04% 465
2021
Q4
$813K Buy
+31,758
New +$877K 0.02% 721
2021
Q3
Sell
-17,985
Closed -$720K 1913
2021
Q2
$720K Buy
+17,985
New +$731K 0.02% 772

Other funds holding MSOS

Prelude Capital Management's MSOS Position: Q1 2026 in Review

Prelude Capital Management sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q1 2026, closing a stake of 93,668 shares — an estimated $442K sold.

Prelude Capital Management first reported a position in MSOS in Q2 2021 and held it in 8 quarters. The position peaked at $1.45M in Q1 2022. 168 funds tracked by Wall St. Rank hold MSOS as of Q1 2026.

  • Prelude Capital Management reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 93,668 AdvisorShares Pure US Cannabis ETF shares in Q1 2026, an estimated $442K.
  • Prelude Capital Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2021 and held it in 8 quarters.
  • Prelude Capital Management's AdvisorShares Pure US Cannabis ETF position peaked at $1.45M in Q1 2022.
  • 168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.